SCHEMBL459999

SCHEMBL459999

CCC(=O)CCC(=O)c1ccc(SC)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.53
SMN1; SMN2 Q16637 2/20 0.53
NPC1 O15118 1/20 0.53
RAB9A P51151 1/20 0.53
HAO1 Q9UJM8 1/20 0.49
PLK1 P53350 1/20 0.46
TAS1R3 Q7RTX0 1/20 0.44
TAS1R1 Q7RTX1 1/20 0.44
MMP2 P08253 1/20 0.43
MMP9 P14780 1/20 0.43
MMP8 P22894 1/20 0.43
HSD17B3 P37058 5/20 0.43
GAA P10253 1/20 0.42
CYP2C19 P33261 1/20 0.42
KMT2A Q03164 1/20 0.42
L3MBTL1 Q9Y468 2/20 0.41
HSP90AA1 P07900 1/20 0.41
KCNH2 Q12809 1/20 0.41
HTR7 P34969 1/20 0.40
HPGD P15428 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10660683 0.84 HAO1 (0.58) ALDH1A1SMN1; SMN2NPC1RAB9AHAO1
SCHEMBL6755453 0.83 HSD17B3 (0.62) SMN1; SMN2HAO1PLK1TAS1R3TAS1R1
SCHEMBL275400 0.83 HAO1 (0.56) ALDH1A1SMN1; SMN2NPC1RAB9AHAO1
SCHEMBL7575160 0.81 NR4A2 (0.59) ALDH1A1SMN1; SMN2NPC1RAB9AHAO1
SCHEMBL461531 0.81 HAO1 (0.51) ALDH1A1SMN1; SMN2NPC1RAB9AHAO1
SCHEMBL5717808 0.81 KMT2A (0.63) ALDH1A1SMN1; SMN2RAB9AHAO1PLK1
SCHEMBL457406 0.80 PLK1 (0.45) ALDH1A1SMN1; SMN2HAO1PLK1TAS1R3
SCHEMBL457696 0.80 HAO1 (0.44) ALDH1A1SMN1; SMN2NPC1RAB9AHAO1
SCHEMBL5190530 0.80 HAO1 (0.50) ALDH1A1SMN1; SMN2NPC1RAB9AHAO1
SCHEMBL7196791 0.79 L3MBTL1 (0.55) NPC1RAB9AHAO1PLK1MMP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2614050-B1 1,5-DIARYL-2-ALKYLPYRROLE-3-SUBSTITUTED NITRO ESTERS, SELECTIVE COX-2 INHIBITORS AND NITRIC OXIDE DONORS Rottapharm Biotech Srl (IT) 2016-01-20 EP disclosed
US-9162979-B2 1,5-Diary1-2-alkylpyrrole-3-substituted nitro esters, selective COX-2 inhibitors and nitric oxide donors ROTTAPHARM BIOTECH S.R.L. (IT) 2015-10-20 US disclosed
EP-2614050-A1 1,5-DIARYL-2-ALKYLPYRROLE-3-SUBSTITUTED NITRO ESTERS, SELECTIVE COX-2 INHIBITORS AND NITRIC OXIDE DONORS Rottapharm S.p.A. (IT) 2013-07-17 EP disclosed
US-20130165494-A1 1,5-Diaryl-2-alkylpyrrole-3-Substituted Nitro Esters, Selective COX-2 Inhibitors and Nitric Oxide Donors ROTTAPHARM S.P.A. (IT) 2013-06-27 US disclosed
WO-2012032479-A1 L,5-DIARYL-2-ALKVLPVRROLE-3-SUBSTITUTED NITRO ESTERS, SELECTIVE COX-2 INHIBITORS AND NITRIC OXIDE DONORS ROTTAPHARM S.P.A. (IT) 2012-03-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130165494-A1 1,5-Diaryl-2-alkylpyrrole-3-Substituted Nitro Esters, Selective COX-2 Inhibitors and Nitric Oxide Donors NOS3, PTGER3, PTGES3 ALDH1A1 2505/4885SMN1; SMN2 2595/4885NPC1 3622/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.